Abbott Laboratories Faces Huge Fines for Off-Label Medication Marketing
The US Food and Drug Administration (FDA) first approved Depakote, a product of Abbott Labs, for treatment of epileptic seizures, bipolar mania, and migraine prevention, in 1978. However, thanks to marketing pushes from the manufacturer, the drug was being widely used for the off-label treatment of a wide variety of psychiatric conditions, including aggression in […]
